+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Animal Sedative Market Size, Share & Trends Analysis Report By Route of Administration, By Animal Type, By Drug Class, By End Use (Hospitals and Specialty Centers), By Application (Surgical, Diagnostic, and Others), By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 135 Pages
  • July 2024
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5988498
The Europe Animal Sedative Market is projected to witness market growth of 5.4% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Animal Sedative Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $33.79 millions by 2031. The UK market is exhibiting a CAGR of 4.5% during (2024 - 2031). Additionally, The France market is projected to experience a CAGR of 6.4% during (2024 - 2031).



Sedatives are crucial in managing large livestock during various procedures, such as hoof trimming, reproductive examinations, surgical interventions, and diagnostic imaging. They help maintain animal calmness and cooperation, ensuring the safety of both animals and veterinary personnel. Sedatives are used similarly for procedures like shearing, vaccinations, and minor surgeries.

Furthermore, sedatives are vital in handling and transporting exotic species in zoological settings. These sedatives are utilized during medical examinations, dental procedures, reproductive assessments, and behavioral studies to mitigate stress and prioritize the safety of both animals and caregivers. Sedatives aid in the medical treatment and rehabilitation of injured or orphaned wild animals, allowing for safe handling during necessary interventions and procedures.

The veterinary sector in Europe is witnessing advancements in medical technology and treatment options, leading to more sophisticated animal procedures and therapies. Many of these procedures, such as advanced surgeries and diagnostic imaging, often necessitate sedation or anesthesia to ensure patient safety and comfort. This trend drives the demand for effective and reliable sedative medications. There is a growing emphasis on animal welfare and minimizing stress during veterinary procedures in Europe. Sedatives play a crucial role in achieving these objectives by helping to calm and relax animals undergoing medical treatment or examinations. As veterinary practices prioritize the well-being of their patients, the demand for safe and efficient sedatives continues to increase. Therefore, the expansion of the animal medicine industry is driving the market's growth.

List of Key Companies Profiled

  • Koninklijke Philips N.V.
  • Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Visiopharm A/S
  • Paige AI, Inc.
  • PathAI, Inc.
  • Aiforia Technologies Plc
  • Indica Labs, Inc.
  • Optrascan, Inc. (Optra Ventures, LLC)
  • MindPeak GmbH

Market Report Segmentation

By Route of Administration
  • Parenteral
  • Oral
By Animal Type
  • Dogs
  • Cats
  • Horses
  • Others
By Drug Class
  • Alpha-2 Adrenergic Receptor Agonists
  • Phenothiazines
  • Benzodiazepines
  • Butyrophenones
  • Others
By End Use
  • Hospitals
  • Specialty Centers
By Application
  • Surgical
  • Diagnostic
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Animal Sedative Market, by Route of Administration
1.4.2 Europe Animal Sedative Market, by Animal Type
1.4.3 Europe Animal Sedative Market, by Drug Class
1.4.4 Europe Animal Sedative Market, by End Use
1.4.5 Europe Animal Sedative Market, by Application
1.4.6 Europe Animal Sedative Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Animal Sedative Market by Route of Administration
4.1 Europe Parenteral Market by Country
4.2 Europe Oral Market by Country
Chapter 5. Europe Animal Sedative Market by Animal Type
5.1 Europe Dogs Market by Country
5.2 Europe Cats Market by Country
5.3 Europe Horses Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Animal Sedative Market by Drug Class
6.1 Europe Alpha-2 Adrenergic Receptor Agonists Market by Country
6.2 Europe Phenothiazines Market by Country
6.3 Europe Benzodiazepines Market by Country
6.4 Europe Butyrophenones Market by Country
6.5 Europe Others Market by Country
Chapter 7. Europe Animal Sedative Market by End Use
7.1 Europe Hospitals Market by Country
7.2 Europe Specialty Centers Market by Country
Chapter 8. Europe Animal Sedative Market by Application
8.1 Europe Surgical Market by Country
8.2 Europe Diagnostic Market by Country
8.3 Europe Others Market by Country
Chapter 9. Europe Animal Sedative Market by Country
9.1 Germany Animal Sedative Market
9.1.1 Germany Animal Sedative Market by Route of Administration
9.1.2 Germany Animal Sedative Market by Animal Type
9.1.3 Germany Animal Sedative Market by Drug Class
9.1.4 Germany Animal Sedative Market by End Use
9.1.5 Germany Animal Sedative Market by Application
9.2 UK Animal Sedative Market
9.2.1 UK Animal Sedative Market by Route of Administration
9.2.2 UK Animal Sedative Market by Animal Type
9.2.3 UK Animal Sedative Market by Drug Class
9.2.4 UK Animal Sedative Market by End Use
9.2.5 UK Animal Sedative Market by Application
9.3 France Animal Sedative Market
9.3.1 France Animal Sedative Market by Route of Administration
9.3.2 France Animal Sedative Market by Animal Type
9.3.3 France Animal Sedative Market by Drug Class
9.3.4 France Animal Sedative Market by End Use
9.3.5 France Animal Sedative Market by Application
9.4 Russia Animal Sedative Market
9.4.1 Russia Animal Sedative Market by Route of Administration
9.4.2 Russia Animal Sedative Market by Animal Type
9.4.3 Russia Animal Sedative Market by Drug Class
9.4.4 Russia Animal Sedative Market by End Use
9.4.5 Russia Animal Sedative Market by Application
9.5 Spain Animal Sedative Market
9.5.1 Spain Animal Sedative Market by Route of Administration
9.5.2 Spain Animal Sedative Market by Animal Type
9.5.3 Spain Animal Sedative Market by Drug Class
9.5.4 Spain Animal Sedative Market by End Use
9.5.5 Spain Animal Sedative Market by Application
9.6 Italy Animal Sedative Market
9.6.1 Italy Animal Sedative Market by Route of Administration
9.6.2 Italy Animal Sedative Market by Animal Type
9.6.3 Italy Animal Sedative Market by Drug Class
9.6.4 Italy Animal Sedative Market by End Use
9.6.5 Italy Animal Sedative Market by Application
9.7 Rest of Europe Animal Sedative Market
9.7.1 Rest of Europe Animal Sedative Market by Route of Administration
9.7.2 Rest of Europe Animal Sedative Market by Animal Type
9.7.3 Rest of Europe Animal Sedative Market by Drug Class
9.7.4 Rest of Europe Animal Sedative Market by End Use
9.7.5 Rest of Europe Animal Sedative Market by Application
Chapter 10. Company Profiles
10.1 Zoetis, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 Virbac
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Product Launches and Product Expansions:
10.2.5 SWOT Analysis
10.3 Dechra Pharmaceuticals PLC
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental & Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Merck & Co., Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 SWOT Analysis
10.5 Bimeda, Inc.
10.5.1 Company Overview
10.5.2 Recent strategies and developments:
10.5.2.1 Product Launches and Product Expansions:
10.5.3 SWOT Analysis
10.6 Ouro Fino Saude Animal Participacoes S.A.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expenses
10.7 vetcare. fi.
10.7.1 Company Overview
10.8 Chanelle Pharma (Exponent)
10.8.1 Company Overview
10.9 Randlab Australia Pty Ltd.
10.9.1 Company Overview
10.10. Troy Laboratories Pty Ltd.
10.10.1 Company Overview

Companies Mentioned

  • Zoetis, Inc.
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Merck & Co., Inc.
  • Bimeda, Inc.
  • Ouro Fino Saude Animal Participacoes S.A.
  • vetcare. fi.
  • Chanelle Pharma (Exponent)
  • Randlab Australia Pty Ltd.
  • Troy Laboratories Pty Ltd.

Methodology

Loading
LOADING...